PROK ProKidney
- 3.080
- +0.270+9.61%
- 3.110
- +0.030+0.97%
ProKidney News
Stocks With More Than 10% Short Interest - Finviz Screener
We're Hopeful That ProKidney (NASDAQ:PROK) Will Use Its Cash Wisely
ProKidney | 10-Q: Quarterly report
ProKidney (PROK.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $0; earnings per share were -0.16 dollars, previous value was -0.16 dollars, and expected value was -0.18 dollars.
ProKidney (PROK.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $0; earnings per share were -0.16 dollars, previous value was -0.16 dollars, and expected value was -0.18 dollars.
ProKidney Q1 Loss Unchanged From Year Earlier
ProKidney (PROK) reported a Q1 net loss Friday of $0.16 per diluted share, unchanged from a year earlier. Two analysts polled by Capital IQ had forecast a Q1 GAAP loss of $0.35 per share. As expected,
ProKidney Q1 EPS $(0.16) Remains Flat YoY, Exits Quarter With Cash & Equivalents Worth $329M
ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.25) by 36 percent. This is unchanged from the same period last year.
ProKidney 1Q Loss/Shr 16c >PROK
ProKidney 1Q Loss/Shr 16c >PROK
ProKidney 1Q Research and Development Expenses $27.2M >PROK
ProKidney 1Q Research and Development Expenses $27.2M >PROK
Press Release: ProKidney Reports Business Updates and First Quarter 2024 Financial Results
ProKidney Reports Business Updates and First Quarter 2024 Financial Results -- Final results from RMCL-002 Phase 2 trial to be presented in the Late Breaking Clinical Trials session at the E
ProKidney(PROK.US) Officer Sells US$43,343.27 in Common Stock
$ProKidney(PROK.US)$ Officer Weber Darin J. sold 17,238 shares of common stock on Apr 18, 22, 2024 at an average price of $2.5144 for a total value of $43,343.27.Source: Announcement What is statement
MRIN, WISA and SMFL Among Mid-day Movers
Lexicon Pharmaceuticals, Bio-Path Holdings, Protara Therapeutics Among Healthcare Movers
Veru, EyePoint Pharmaceuticals, SINTX Technologies Among Healthcare Movers
ProKidney(PROK.US) Officer Sells US$43,095 in Common Stock
$ProKidney(PROK.US)$ Officer Weber Darin J. sold 17,238 shares of common stock on Apr 16, 2024 at an average price of $2.5 for a total value of $43,095.Source: Announcement What is statement of change
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersTrevena (NASDAQ:TRVN) shares increased by 27.0% to $0.51 during Wednesday's after-market session. The company's market cap stands at $9.2 million. Mustang Bio (NASDAQ:MBIO) stock increased by 1
Lexaria Bioscience, Biosig Technologies, BIMI Holdings Among Healthcare Movers
ProKidney(PROK.US) Officer Sells US$146.01K in Common Stock
$ProKidney(PROK.US)$ Officer Weber Darin J. sold 84,403 shares of common stock on Apr 1, 12, 2024 at an average price of $1.73 for a total value of $146.01K.Source: Announcement What is statement of c
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d
BSGM, ENLV and WISA Among Mid-day Movers
12 Health Care Stocks Moving In Monday's Intraday Session
GainersLongeveron (NASDAQ:LGVN) stock moved upwards by 44.4% to $2.44 during Monday's regular session. The market value of their outstanding shares is at $7.7 million. Mobile-health Network (NASDAQ:MN
Analysis
Price Target
No Data
